SARS-CoV-2-IN-17
SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand[1].
Product Specifications
CAS Number
[2761911-44-6]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-17.html
Solubility
10 mM in DMSO
Smiles
O=C(NC(C=CC=C12)=C2N(CC)CC3=C1C=C(OC)C(OC)=C3)C(F)(F)F
Molecular Formula
C19H19F3N2O3
Molecular Weight
380.36
References & Citations
[1]Yi-Ting Wang, et al. Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2. Eur J Med Chem. 2022 Jan 5;227:113966.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MAGEA6, CT (Melanoma-associated Antigen 6, MAGE-6 Antigen, MAGE-3B Antigen, Cancer/Testis Antigen 1.6, CT1.6, MAGE6) (APC)
MAGEA6, CT (Melanoma-associated Antigen 6, MAGE-6 Antigen, MAGE-3B Antigen, Cancer/Testis Antigen 1.6, CT1.6, MAGE6) (APC)
GJB1 (Gap Junction beta-1 Protein, Connexin-32, Cx32, GAP Junction 28kD Liver Protein, CX32) (HRP)